Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
ItalyLong-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II
ItalyStudy on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure
ItalyStudy on the Effects and Safety of Rilzabrutinib for Adults with Warm Autoimmune Hemolytic Anemia
ItalyStudy of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
ItalyStudy on the Safety and Effects of Englumafusp Alfa with Obinutuzumab and Glofitamab for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
ItalyStudy of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment
ItalyStudy on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer
ItalyLong-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen
ItalyStudy on the Safety and Effects of AZD5305 with Hormonal Agents for Patients with Metastatic Prostate Cancer
ItalyStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
ItalyStudy on the Effects and Safety of Crovalimab for Adults and Adolescents with Atypical Hemolytic Uremic Syndrome (aHUS)
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
